Board MeetingMay 5, 2026, 08:32 AM
Achieve Life Sciences to Report Q1 2026 Results May 12
AI Summary
Achieve Life Sciences, Inc. announced it will report its first quarter 2026 financial results and provide a corporate update on Tuesday, May 12, 2026, at 8:30 AM EDT. Investors can access the event via webcast or a live conference call. The company also highlighted that the FDA has set a Prescription Drug User Fee Act (PDUFA) date of June 20, 2026, for its New Drug Application for cytisinicline.
Key Highlights
- Achieve Life Sciences to report Q1 2026 financial results and provide a corporate update on May 12, 2026.
- The earnings call is scheduled for 8:30 AM EDT.
- Access to the webcast is available via a provided link.
- Live conference call can be accessed by dialing 877-269-7756 (U.S. & Canada) or +1 201-689-7817 (International).
- Conference ID for the call is 13759781.
- A webcast replay will be available approximately three hours after the call and archived for 90 days.
- The FDA has assigned a PDUFA date of June 20, 2026, for cytisinicline's NDA.